Form D Explorer

Source evidence

ViCardia Therapeutics, Inc. · 0002135564-26-000001

D filed May 21, 2026. Extracted source facts are preserved separately from the current issuer profile and normalized display values.

SEC filing indexDownload stored sourceReport a record issue

Explicit source references

These accession references come from the source document. They describe a reported link; they do not establish new financing or an independently verified offering group.

Identity as reported in this document

city
SAN FRANCISCO
street1
530 BUSH STREET, SUITE 802
zipCode
94108
entityName
ViCardia Therapeutics, Inc.
entityType
Corporation
stateOrCountry
CA
jurisdictionOfInc
DELAWARE
Individual source fields, including raw text and value state
FieldRaw sourceStateParsed valueSource location
Reported finders fees0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/findersFees/dollarAmount
Reported amount sold700000number700000/edgarSubmission/offeringData/offeringSalesAmounts/totalAmountSold
Reported sales commissions0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/salesCommissions/dollarAmount
Reported offering amount700000number700000/edgarSubmission/offeringData/offeringSalesAmounts/totalOfferingAmount
Reported minimum investment10000number10000/edgarSubmission/offeringData/minimumInvestmentAccepted
Reported investor count1number1/edgarSubmission/offeringData/investors/totalNumberAlreadyInvested

Document SHA-256: 2905be058bffb9192e8612cb1ff82f40a31566812f8d87563b7adf83d840ebc9. This proves extraction identity, not the accuracy of the filer's claims.